US Stock Market Movement: Alamar Biosciences surges on October 5th driven by Alzheimer’s, performance growth, and proteomics
Bitget异动解读2026/10/05 18:35Alamar Biosciences October 5 Surge Interpretation
Keywords: Alzheimer, performance growth, proteomics
1. On September 24, a longitudinal cohort study on Alzheimer's disease supported by the company's technology was published in The Lancet Neurology. The study used NULISAseq™ CNS 120 to detect 130 types of plasma proteins and analyzed 2,385 samples from 1,967 participants, showing differences in proteins related to amyloid protein clearance and cognitive decline.
2. On August 10, the company reported second quarter 2026 revenue of $29.4 million, up 82% year-on-year; consumables revenue was $15.5 million, up 147% year-on-year; gross margin reached 60%, and full-year 2026 revenue is expected to be $116 million to $120 million, with the midpoint representing a 59% year-on-year increase.
3. On August 10, the company expanded its strategic cooperation with the Alzheimer's Disease Data Initiative and Gates Ventures, adding 86,000 plasma sample analyses, with the combined dataset expected to exceed 140,000 samples; meanwhile, it launched NULISAseq™ Neuro 220 and Immune 340 Panel to expand research applications in neurological diseases and immunity.
(Disclaimer: This content is collected and summarized from public information by AI technology, and is for reference only. It does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CME Fed Watch: Probability of keeping interest rates unchanged in October is 77.3%
According to CME "FedWatch": there is a 77.3% probability that the Federal Reserve will keep interest rates unchanged by October, and a 22.7% probability of a cumulative 25 basis point rate hike. By December, there is a 13.4% probability that rates will remain unchanged, a 67.8% probability of a cumulative 25 basis point hike, and an 18.8% probability of a cumulative 50 basis point increase.
Nvidia's stock price hits a new high in four months; analysts optimistic about the outlook
As Nvidia (NVDA.US) shares hit a new high for the first time in four months, analysts remain optimistic about its future. The company's stock closed at $237.58 on Monday, setting a new peak, and the company's market value is around 5.76 trillions USD. Wedbush analyst Matt Bryson noted that as Nvidia gets closer to meeting its future financial expectations, "it's increasingly difficult for the market to ignore the disconnect" between its growth prospects and its valuation. He pointed out that the company is expected to grow at a 70% rate, but the stock is trading at less than 20 times next year's expected earnings per share, making it appear relatively inexpensive. Despite facing competition from peers and even its own customers, Nvidia remains the "cornerstone of AI infrastructure," BNP Paribas analyst Karl Ackerman wrote in a report last week. He raised the stock’s price target to $345 per share, which implies a 45% upside compared to Monday's closing price.
Bank of America and others launch $60 billion financing to support Anthropic leasing Google AI chips
According to the Financial Times, Bank of America, Citigroup, and Morgan Stanley have begun distributing a total debt financing package of $60 billion to other banks, to support Anthropic’s leasing of Google (GOOG.US) AI chips in what is the largest chip financing deal to date. Of this amount, approximately $42 billion consists of senior secured loans backed by Broadcom (AVGO.US), with syndication launching on Monday; an additional $18 billion, a tranche of subordinated debt without Broadcom’s backing, is expected to be launched later, with Blackstone committed to providing about $9 billion of the funding. The funds raised will support Anthropic’s chip orders for 2027, with lease payments beginning after chip delivery. Broadcom may also receive up to $42 billion in convertible notes from Anthropic as payment for related leasing costs. This $60 billion financing is being seen as a key test of market demand for AI-related debt.

Wall Street banks launch $60 billion chip deal for Broadcom and Anthropic
According to the Financial Times, Wall Street banks have launched a record-breaking $60 billion chip deal involving Broadcom and Anthropic.